key: cord-0749390-zy2pr76a authors: Costa, Tiago J.; Potje, Simone R.; Fraga-Silva, Thais F.C.; da Silva-Neto, Júlio A.; Barros, Paula R.; Rodrigues, Daniel; Machado, Mirele R.; Martins, Ronaldo B.; Santos-Eichler, Rosangela A.; Benatti, Maira N.; de Sá, Keyla S.G.; Almado, Carlos Eduardo L.; Castro, Ítalo A.; Pontelli, Marjorie C.; Serra, Leonardo La; Carneiro, Fernando S.; Becari, Christiane; Louzada-Junior, Paulo; Oliveira, Rene D.R.; Zamboni, Dario S.; Arruda, Eurico; Auxiliadora-Martins, Maria; Giachini, Fernanda R.C.; Bonato, Vânia L.D.; Zachara, Natasha E.; Bomfim, Gisele F.; Tostes, Rita C. title: Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage date: 2021-11-25 journal: Vascul Pharmacol DOI: 10.1016/j.vph.2021.106946 sha: 856b0d26b793d4f222681c1c6d95ce8b0dc1a6bc doc_id: 749390 cord_uid: zy2pr76a BACKGROUND AND PURPOSE: Mitochondria play a central role in the host response to viral infection and immunity, being key to antiviral signaling and exacerbating inflammatory processes. Mitochondria and Toll-like receptor (TLR) have been suggested as potential targets in SARS-CoV-2 infection. However, the involvement of TLR9 in SARS-Cov-2-induced endothelial dysfunction and potential contribution to cardiovascular complications in COVID-19 have not been demonstrated. This study determined whether infection of endothelial cells by SARS-CoV-2 affects mitochondrial function and induces mitochondrial DNA (mtDNA) release. We also questioned whether TLR9 signaling mediates the inflammatory responses induced by SARS-CoV-2 in endothelial cells. EXPERIMENTAL APPROACH: Human umbilical vein endothelial cells (HUVECs) were infected by SARS-CoV-2 and immunofluorescence was used to confirm the infection. Mitochondrial function was analyzed by specific probes and mtDNA levels by real-time polymerase chain reaction (RT-PCR). Inflammatory markers were measured by ELISA, protein expression by western blot, intracellular calcium (Ca(2+)) by FLUOR-4, and vascular reactivity with a myography. KEY RESULTS: SARS-CoV-2 infected HUVECs, which express ACE2 and TMPRSS2 proteins, and promoted mitochondrial dysfunction, i.e. it increased mitochondria-derived superoxide anion, mitochondrial membrane potential, and mtDNA release, leading to activation of TLR9 and NF-kB, and release of cytokines. SARS-CoV-2 also decreased nitric oxide synthase (eNOS) expression and inhibited Ca(2+) responses in endothelial cells. TLR9 blockade reduced SARS-CoV-2-induced IL-6 release and prevented decreased eNOS expression. mtDNA increased vascular reactivity to endothelin-1 (ET-1) in arteries from wild type, but not TLR9 knockout mice. These events were recapitulated in serum samples from COVID-19 patients, that exhibited increased levels of mtDNA compared to sex- and age-matched healthy subjects and patients with comorbidities. CONCLUSION AND APPLICATIONS: SARS-CoV-2 infection impairs mitochondrial function and activates TLR9 signaling in endothelial cells. TLR9 triggers inflammatory responses that lead to endothelial cell dysfunction, potentially contributing to the severity of symptoms in COVID-19. Targeting mitochondrial metabolic pathways may help to define novel therapeutic strategies for COVID-19. The recently human-pathogenic β-coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is responsible for the global pandemic coronavirus disease 2019 (COVID- 19) 1 Infection of extrapulmonary cells by SARS-CoV-2, also contributes to the strength of the inflammatory response 5 . SARS-CoV-2 RNA was also detected in heart, kidneys, liver, spleen, lymph nodes, muscle, and intestine of patients with COVID-19 6 . Extra-respiratory clinical manifestations, with cardiac, renal, neurological, and hematological symptoms as well as multiple organ failure, have been consistently reported in COVID-19 patients 7 . In the cardiovascular system, SARS-CoV-2 infection promotes venous thromboembolic events 8 , cardiac injury and dysrhythmias, angiogenesis, and glycocalyx shedding 9; 10 . Of importance, microvascular thrombi formation, with complete stagnated capillaries and thromboembolic occlusion, is not restricted to the lungs and has been reported in the systemic circulation 11 . However, the infection of SARS-CoV-2 in endothelial cells of vascular system not well characterized. Mitochondria are key to antiviral signaling [mitochondria serves as a signaling platform for mitochondrial anti-viral signal (MAVS)], but also contribute to exacerbated inflammatory processes 12 . Mitochondrial dysfunction increases reactive oxygen species (ROS) production, alters calcium (Ca 2+ ) homeostasis, deregulates lipid metabolism, and leads to release of mitochondrial DNA (mtDNA) 13; 14 . Circulating mtDNA, whose primary source is cell injury and necrosis, is also found in patients affected by multiple systemic conditions, as observed in ARDS 15 and arterial hypertension 16; 17 . ROS and Ca 2+ are important to vascular homeostasis , and redox disbalance, abnormal Ca 2+ handling, and chronic inflammation are all key hallmarks in cardiovascular pathological processes. mtDNA, released by damaged cells and tissues, is recognized by endosomal/extracellular TLR9 triggering inflammation. TLR9 is activated by cytosinephosphate-guanine (CpG)-rich unmethylated DNA motifs , which are primarily found in bacterial, mitochondrial, and fetal DNA but rarely in vertebrate adult DNA (genomic DNA) 18 . TLR9 responds to herpes DNA virus 19 as well as to dengue RNA virus 20 . However, whether SARS-CoV-2 infection activates TLR9 is unknown. TLR9, expressed in endothelial cells (ECs) and vascular smooth muscle cells (VSMCs), contributes to endothelial and vascular dysfunction. Prolonged activation of TLR9 causes vascular hypertrophy, fibrosis, and abnormal reactivity by mechanisms that involve ROS generation, decreased NO bioavailability, augmented expression of proinflammatory cytokines, and activation of autophagic and pro-contractile pathways 16; 17; 21 . Considering that SARS-CoV-2 infection produces signs of mitochondrial dysfunction 22 , e.g. increased ROS generation in the lungs 23 and low levels of Ca 2+ in J o u r n a l P r e -p r o o f Journal Pre-proof the blood 24 , in the present study we tested the hypothesis that SARS-CoV-2 infection of endothelial cells promotes mitochondrial dysfunction, increases mtDNA levels and activates TLR9 signaling, leading to endothelial dysfunction. Therefore, the aims of this study were: 1) to determine mtDNA levels in control and SARS-CoV-2-infected endothelial cells as well as in serum of COVID-19 patients; 2) to evaluate the impact of SARSCoV-2-infection in mitochondrial function of endothelial cells, and 3) to investigate the molecular mechanisms involved in SARS-CoV-2-induced endothelial cell dysfunction. The Brazilian National Committee for Ethics in Research (CONEP) approved all procedures performed in the study (CONEP CAAE: 30248420.9.0000.5440 and 30816620.0.0000.5440) and the investigation conforms with the principles outlined in the Declaration of Helsinki. In addition, written informed consent was obtained from all recruited patients before entering study. We included male and female patients older than 18 years-old, with confirmed moderate or severe forms of COVID-19 (n=19) ( Analysis of anti-SARS-CoV-2 IgG and IgM antibodies was performed in serum from COVID-19 negative subjects (control) and COVID-19 patients using the rapid test (https://consultas.anvisa.gov.br/#/saude/q/?numeroRegistro=80198110005). The control group comprises subjects whose samples were used in a previous study 10 . Considering that microvascular thrombi formation, with complete stagnated capillaries and thromboembolic occlusion, is not restricted to the lungs and has been reported in the systemic circulation 11 Scytek Laboratories, Utah, USA). Counterstaining was performed with Harris hematoxylin and slides were mounted with coverslips with aqueous mounting medium. Slides were scanned using a VS120 ScanScope (Olympus) at 400x magnification. SARS-CoV-2 genome quantification was done according Lu et al 2020 26 . Briefly, RNA was extracted by Trizol ® (Invitrogen, CA, EUA), and amplification was done by one-step real-time RT-PCR using a Step-One Plus real-time PCR thermocycler (Applied Biosystems, Foster City, CA, USA). 100 ng of RNA was used for genome amplification, adding specifics primers (20 µM), probe (5 µM), and qPCRBIO Probe 1- Step Go Master Mix (PCRbiosystems, London, UK), with the following cycling parameters: 45°C for 10 min, 95°C for 2 min, followed by 40 cycles of 95 °C for 5 s, and 60 °C for 30s. To assess the viral load of SARS-CoV-2, a standard curve was constructed using plasmid contains the N gene insert (944 bp amplicon). Resistance mesenteric arteries were submitted to a normalization procedure. After a 60min equilibration period, vessels were initially exposed to 120 mM KCl to determine the functional integrity of smooth muscle cells. Endothelial integrity was assessed by testing the relaxant effect of ACh (10 -6 M) in vessels contracted with phenylephrine (~ 80% maximum response -10 -6 M). Concentration-response curves to ET-1 (10 -10 to 3x10 -7 M) were performed in mesenteric resistance arteries from wild type and Immunofluorescence analysis, using an anti-SARS-CoV-2 rabbit polyclonal antibody and the FITC-labelled goat anti-rabbit IgG antibody Apl24F, demonstrates that HUVECs are infected with SARS-CoV-2. Fluorescence intensity in SARS-CoV-2infected HUVECs was 13% higher compared with fluorescence in MOCK-treated cells. Vero-E6 cells infected with SARS-CoV-2, used as a positive control, presented a more significant infection than HUVECs (Figures 1A, 1B and 1C) . Mitochondrial membrane potential, determined by MitoTracker® Red CMXRos, did not differ among control cells (cells in virus-free MOCK medium, and cells exposed to UV-inactivated SARS-CoV-2 (Supplementary Figure 2) , but was increased in HUVECs infected by SARS-CoV-2 ( Figures 3C and 3D) . (Figures 4A-4E) . ATP-induced Ca 2+ responses were also abolished in HUVECs infect by SARS-CoV-2 compared with cells in virus-free MOCK medium or exposed to UV-inactivated SARS-CoV-2 ( Figures 4F and 4G) . These data suggest that SARS-CoV-2 induces mitochondrial dysfunction in HUVECs, an effect associated with loss of ability to respond to Ca 2++ -mobilizing agents. Since mitochondrial dysfunction and mtDNA release have been shown to activate TLR9 responses, TLR9 signaling was investigated. TLR9 protein levels increased in SARS-Cov-2-infected HUVECs (48 h post-infection) compared with cells in virus-free MOCK medium or HUVECs exposed to UV-inactivated virus. TLR9 expression at 24 h was not altered, suggesting that the effect is time-dependent ( Figure 5A ). Myd88 expression did not differ among the groups (data not shown). SARS-CoV- Figure 3D) . Considering that SARS-CoV-2 induces endothelial cell dysfunction linked to mtDNA leakage and TLR9 activation, we investigated whether mtDNA, a TLR9 agonist, affects vascular reactivity. mtDNA, but not genomic DNA (gDNA) increased vasoconstriction to ET-1 ( Figure 5G ). mtDNA effects on ET-1 vascular reactivity were not observed in arteries from TLR9KO mice ( Figure 5H ). These results indicate that, in addition to promoting endothelial cell dysfunction, SARS-CoV-2 infection negatively impacts vascular function since endothelium-derived key vasoactive factors as well as mtDNA and TLR9 activation impair vascular responses. The present study shows that SARS-CoV-2 infection of endothelial cells induces cell damage by promoting mitochondrial dysfunction, mtDNA release, TLR9 activation, leading to impaired Ca 2+ responses, increased IL-6 levels. Of importance, mtDNA is increased in serum from COVID-19 patients (Graphical Abstract). Although ACE-2 expression was identified in endothelial cells, we did not observe viral replication in these cells partially supporting a previous report 30 Although in vivo data suggest that TLR9 activation by mtDNA regulates vasoconstriction, there is a lack of in vitro study addressing the direct interaction of endothelial TLR9 and mtDNA. Activation of TLR9 may be a silent, but driving force that explains hyperinflammation and thrombotic complications caused by SARS-CoV-2 61 . Corroborating the data reported in HUVECs and translating these data to a clinical model, plasma of patients with COVID-19 exhibit increased mtDNA when compared to non-infected patients. Plasma mtDNA may be linked to apoptosis and necrosis of many cell types, including endothelial cells, as shown in the present study. Our study contributes to the understanding of how SARS-CoV-2 induces endothelial cells dysfunction and opens new perspectives for better therapeutic approaches. The authors declare no conflict of interest. This study was supported by Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients Multiorgan and Renal Tropism of SARS-CoV-2 Extrapulmonary manifestations of COVID-19 Venous Thromboembolism among Hospitalized Patients with COVID-19 Undergoing Thromboprophylaxis: A Systematic Review and Meta-Analysis Injury to the Endothelial Glycocalyx in Critically Ill Patients with COVID-19 Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patients In vivo demonstration of microvascular thrombosis in severe COVID-19 Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell, v. 122, n. 5, p Mitochondrial diseases. Nat Rev Dis Primers Potential contribution of mitochondrial DNA damage associated molecular patterns in transfusion products to the development of acute respiratory distress syndrome after multiple transfusions Circulating mitochondrial DNA and Toll-like receptor 9 are associated with vascular dysfunction in spontaneously hypertensive rats Mitochondrial DNA: A new driver for sex differences in spontaneous hypertension A Toll-like receptor recognizes bacterial DNA. Nature, v. 408, n. 6813 Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells Infection with the dengue RNA virus activates TLR9 signaling in human dendritic cells The role of TLR9 in stress-dependent autophagy formation Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19 Is Low Alveolar Type II Cell Low serum calcium: a new, important indicator of COVID-19 patients from mild/moderate to severe/critical A minimal common outcome measure set for COVID-19 clinical research US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg Infect Dis Viral calciomics: interplays between Ca2+ and virus VDAC regulation of mitochondrial calcium flux: From channel biophysics to disease COVID-19 is, in the end, an endothelial disease Lack of Evidence of Angiotensin-Converting Enzyme 2 Expression and Replicative Infection by SARS-CoV-2 in Human Endothelial Cells. Circulation, v. 143, n. 8 Classical and alternative receptors for SARS-CoV-2 therapeutic strategy CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 and are differentially expressed in lung and kidney epithelial and endothelial cells. bioRxiv In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs Evolving functions of endothelial cells in inflammation Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19 A Multiple-Hit Hypothesis Involving Reactive Oxygen Species and Myeloperoxidase Explains Clinical Deterioration and Fatality in COVID-19 Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency. Microbes Infect, v. 22, n. 4-5 Mitochondrial DNA in inflammation and immunity Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature, v. 464, n. 7285 SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus the Cross Fire of SARS-CoV-2 and Immunity. iScience Mitochondrial damage induced by conditions of oxidative stress Accessory subunits are integral for assembly and function of human mitochondrial complex I. Nature, v. 538, n. 7623 Concerning the relation of the Krebs cycle to virus propagation Some energy relations in a hostvirus system Mitochondrial complex I activity is impaired during HIV-1-induced T-cell apoptosis Respiratory syncytial virus co-opts host mitochondrial function to favour infectious virus production. Elife, v. 8, 06 2019 Cellular Organelles Reorganization During Zika Virus Infection of Human Cells. Front Microbiol A CaPful of mechanisms regulating the mitochondrial permeability transition Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease Mitochondrial respiratory complex I: structure, function and implication in human diseases Calcium signalling in endothelial cells Recombinant expression of the voltage-dependent anion channel enhances the transfer of Ca2+ microdomains to mitochondria Toll-like receptor 9 protects non-immune cells from stress by modulating mitochondrial ATP synthesis through the inhibition of SERCA2 TLR9 mediates cellular protection by modulating energy metabolism in cardiomyocytes and neurons Intra-genome variability in the dinucleotide composition of SARS-CoV-2. Virus Evol A Multidisciplinary Theory of a Multifaceted Therapeutic Target IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra) Endotheliitis, endothelin, and endothelin receptor blockers in COVID-19 Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of pregnant rats Clinical and immunological features of severe and moderate coronavirus disease 2019 The authors thanks Carla P. Manzato for excellent technical assistance and Prof Dr Emer Suavinho Ferro for laboratory support (FAPESP grant 16/04000-3). All authors approved the manuscript. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.